Burrill & Company assists life science companies to identify, negotiate and close strategic partnerships, M&A transactions and financings. We provide access to resources, technologies or collaborations essential for executing company business plans. Burrill & Company also works with major life science companies to spin out internal assets and capitalize on their value, ranging from the outright sale of products or businesses to the creation of new companies to exploit these assets. Burrill uses its extensive network to help companies to identify, assess and capture (“spin-in”) products and companies strategic to building their businesses.